Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001199835-16-000710
Filing Date
2016-04-01
Accepted
2016-04-01 15:13:18
Documents
39
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 GALILEO LIFE SCIENCES, INC. 10Q #16804 galileo_10q-16804.htm 10-Q 505664
2 SECTION 302 CERTIFICATION OF CHIEF EXECUTIVE OFFICER exhibit_31-1.htm EX-31.1 11541
3 SECTION 302 CERTIFICATION OF CHIEF FINANCIAL OFFICER exhibit_31-2.htm EX-31.2 11503
4 SECTION 906 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER exhibit_32-1.htm EX-32.1 7816
  Complete submission text file 0001199835-16-000710.txt   1503013

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mdrm-20150331.xml EX-101.INS 116539
6 XBRL TAXONOMY EXTENSION SCHEMA mdrm-20150331.xsd EX-101.SCH 21210
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mdrm-20150331_cal.xml EX-101.CAL 37444
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mdrm-20150331_def.xml EX-101.DEF 24751
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdrm-20150331_lab.xml EX-101.LAB 136272
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdrm-20150331_pre.xml EX-101.PRE 98315
Mailing Address 350 1 FIRST CANADIAN PLACE BOARD OF TRADE TOWER TORONTO A6 M5X1C1
Business Address 350 1 FIRST CANADIAN PLACE BOARD OF TRADE TOWER TORONTO A6 M5X1C1 (416)-642-2593
Galileo Life Sciences, Inc. (Filer) CIK: 0001497165 (see all company filings)

EIN.: 274677038 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-168983 | Film No.: 161546732
SIC: 2834 Pharmaceutical Preparations